Bicara Therapeutics Inc. ...

NASDAQ: BCAX · Real-Time Price · USD
8.70
-0.11 (-1.25%)
At close: Jun 27, 2025, 3:59 PM
8.71
0.11%
After-hours: Jun 27, 2025, 04:34 PM EDT
-1.25%
Bid 8.6
Market Cap 474.47M
Revenue (ttm) n/a
Net Income (ttm) -90.06M
EPS (ttm) -1.69
PE Ratio (ttm) -5.15
Forward PE -3.36
Analyst Buy
Ask 9.58
Volume 363,062
Avg. Volume (20D) 847,069
Open 8.79
Previous Close 8.81
Day's Range 8.66 - 9.02
52-Week Range 7.80 - 28.09
Beta -2.39

About BCAX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCAX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BCAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
-40.8%
Bicara Therapeutics shares are trading lower after... Unlock content with Pro Subscription
1 month ago
+7.33%
Bicara Therapeutics shares are trading lower after the company announced a publication of phase 1/1b trial data for ficerafusp alfa showing mixed results, with median survival still unreached and limited clarity on long-term efficacy.